TransMedics (NASDAQ: TMDX ) stock is climbing higher on Tuesday following the release of the company's earnings report for the third quarter of 2023. Incredibly high revenue of $66.43 million is on...

TransMedics Group Inc. shares TMDX, -5.70% jumped more than 40% premarket on Tuesday after the company reported third-quarter results reflecting growing demand for its organ-transplant services and...

TransMedics Group, Inc. (NASDAQ:TMDX ) Q3 2023 Earnings Call Transcript November 6, 2023 4:30 PM ET Company Participants Brian Johnston - Gilmartin Group Waleed Hassanein - President and CEO Stephe...

TransMedic's Organ Care System is revolutionizing the organ transplant industry. However, the company's acquisition of a charter flight operator has worried the market.

Today, we put the focus on TransMedics Group, Inc., a healthcare company focused on transforming the organ transport and transplant industry. The company recently acquired Summit Aviation, a charte...

TransMedics is a medical tech company focused on organ transplants in the US. TMDX looks set to be a key enabler in raising the transplant volumes carried out in the country. TMDX has experienced s...

Hospitals and transplant centers increasingly rely on TransMedics Group to retrieve donated hearts, lungs, and livers, and deliver them long distances. At the heart of TransMedic Group's operation ...

TransMedics' (TMDX) acquisition of Summit Aviation is likely to help establish TransMedics Aviation, the first integrated national provider of air logistics dedicated exclusively to organ transplan...